COVID-19 Clinical Study Details
If you have COVID-19 and an underlying health condition such as diabetes, heart disease, obesity, or high blood pressure, you may qualify for a clinical research study testing an investigational treatment aimed at reducing serious complications. Expert medical care and no-cost participation are provided.
Now Recruiting Covid Volunteers at Miami, Hollywood, Boynton and Weston
This COVID-19 clinical trial is enrolling adults with preexisting conditions including type 2 diabetes, heart disease, obesity, and high blood pressure who are seeking access to an investigational treatment. Researchers are studying whether this investigational therapy can lower the risk of severe complications in high-risk patients. Participants receive close monitoring from experienced clinical staff at no cost. If you have COVID-19 with underlying health conditions and want to help advance treatment options, you may be eligible to enroll today.
Apply To This Study Here
Please enter your name, a valid phone number, and a valid email address where you can be contacted.
Yes, if you have a confirmed positive test for COVID-19 (via PCR or rapid antigen test) collected within 4 days prior to enrollment, you may be eligible. Additionally, you should have started experiencing at least two COVID-19 symptoms within the last 4 days, with at least one being moderate or severe.
This study is designed for individuals at higher risk of severe illness from COVID-19. You may qualify if you are 75 years or older, have certain chronic conditions (like cancer, kidney disease, or diabetes), are immunocompromised, or have multiple risk factors such as obesity, heart disease, or lung conditions.
Yes, individuals without current symptoms can be enrolled under specific conditions. However, if you develop symptoms later, you’ll need to meet the full eligibility criteria related to symptom onset and testing.
If you’re unable to take certain approved COVID-19 treatments (like NMV/r) due to drug interactions, medical conditions, or other reasons, you may still be eligible for this study. The study is specifically looking at alternative treatment options for such individuals.
Yes, participants must be 18 years of age or older at the time of providing informed consent.
Male participants must agree to use effective contraception or abstain from penile-vaginal intercourse during the study and for at least 3 months after the last dose. Female participants of childbearing potential must use highly effective contraception during the study and for at least 4 days after the last dose. Pregnant or breastfeeding women are not eligible to participate
Benefits of participating in this study
There are multiple ways you can benefit from joining us in this study. Here are some of them.
Study-related visits, evaluations, and close health monitoring are provided at no cost to participants.
Study visits include complimentary meals and transportation assistance for your appointment day.
Your participation helps researchers better understand medical conditions in a way that may benefit others, including friends, family, and future generations.